Phase 3 Fibromyalgia Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Axsome Therapeutics, Inc.620 enrolled16 locationsNCT07398417
Not Yet Recruiting
Phase 3
Intermittent infusion of lidocaine, magnesium sulphate and ketamine in the treatment of neuropathic pain, Chronic Regional Pain Syndrome and fibromyalgia. A pilot study.
FibromyalgiaNeuropathic Pain
Daniel Ellyard30 enrolled1 locationACTRN12619000494134